Allergy Therapeutics: A story of resilience and transformation
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) is writing a story of resilience and transformation. Putting behind it manufacturing setbacks, the company has...…
0,076€
14,77%
Echtzeit-Aktienkurs Allergy Therapeutics PLC
Bid:
Ask:
Nachrichten zur Allergy Therapeutics PLC Aktie
Allergy Therapeutics unveils encouraging early data from peanut trial
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) has announced encouraging interim findings from its phase I/IIa VLP Peanut PROTECT trial aimed at…
Allergy Therapeutics begins paediatric trial for grass allergy treatment
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) has commenced a phase III trial to test the long-term safety and effectiveness of its…
Allergy Therapeutics applies for full marketing approval for grass allergy jab
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) marked a significant milestone after it applied for regulatory approval of its new grass allergy...…
Global Allergy Therapeutics Market Size To Exceed USD 42.5 Billion By 2033 | CAGR Of 6.29%
The Global Allergy Therapeutics Market Size was Valued at USD 23.1 Billion in 2023 and the Worldwide Allergy Therapeutics Market…
Allergy Therapeutics jumps 23% on success of grass allergy vaccine trial
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) shares gesundheited 23% higher to a six-month peak of 1.83p after reporting success from a…
Allergy Therapeutics shares plunge on expected loss and revenue drop
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Allergy Therapeutics Shares Fall on Lower FY 2023 Revenue, Swing to Loss
Allergy Therapeutics Shares Fall on Lower FY 2023 Revenue, Swing to Loss...…
Allergy Therapeutics appoints new CFO; interim CFO to leave in August
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Allergy Therapeutics Appoints Shaun Furlong CFO
Allergy Therapeutics Appoints Shaun Furlong CFO...…
XFRA : HHU: Wiederaufnahme/Resumption
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING…
Allergy Therapeutics banks on second half-year to boost revenue
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Allergy Therapeutics Shares Fall on Going Concern Uncertainty
Allergy Therapeutics Shares Fall on Going Concern Uncertainty...…
Allergy Therapeutics agrees bail out by two large shareholders
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Allergy Therapeutics Agrees on Financing Package, Equity Issue
Allergy Therapeutics Agrees on Financing Package, Equity Issue...…
Allergy Therapeutics doses first patients with peanut allergy vaccine
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Global Food Allergy Diagnostics & Therapeutics Market 2022 - 2027: Featuring Allergy Therapeutics, Astra Biotech, Biomerieux and Danaher Among Others
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "Global Food Allergy Diagnostics & Therapeutics Market (2022-2027) by Product Type, Source, End-user,…
Allergy Therapeutics revenue drops but optimistic about funding
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Allergy Therapeutics 1H Revenue Fell on Production Pause, Streamlining
Allergy Therapeutics 1H Revenue Fell on Production Pause, Streamlining...…
Allergy Therapeutics confident about the direction of funding ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
XFRA : HHU: Aussetzung/Suspension
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME …
XFRA : INSTRUMENT_SUSPENSION - GB00B02LCQ05
Instrument ID [4329746] (HHU - GB00B02LCQ05) suspended...…